Company: RPTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001193125-25-103764
Chunk: 54

Company: Repare Therapeutics Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 54
---
 Agreement, Mr. Segal will provide consulting services to the Company for up to three months following April 11, 2025, pursuant to which the Company will pay Mr. Segal an hourly rate of $800, less applicable deductions and withholdings, for the time spent on such services. In addition, the Company will provide Mr. Segal with the following separation payments and benefits: (i) a lump sum payment of $735,583, less applicable deductions and withholdings, representing 14 months of Mr. Segal’s base salary; (ii) an additional lump sum payment of $86,695, less applicable deductions and withholdings, representing Mr. Segal’s target annual bonus for 2025, pro-rated for the period of Mr. Segal’s service with the Company from January 1, 2025 through April 11, 2025; (iii) continued participation in the Company’s group health and family benefits programs (except for life insurance, short-term and long-term disability) for a period of 12 months following April 11, 2025; (iv) continued eligibility for Mr. Segal and his eligible dependents, at the Company’s expense, for a period of 12 months following April 11, 2025, to an annual medical evaluation and a comprehensive executive health plan with a reputable service provider of Mr. Segal’s choice; (v) payment of up to $5,000 for professional accounting and tax preparation and advice services incurred by Mr. Segal during the 12-month period following April 11, 2025; and (vi) the accelerated vesting of all unvested option awards and restricted stock unit awards that are subject to a time-based vesting schedule held by Mr. Segal as if Mr. Segal had remained employed for an additional 15 months following April 11, 2025, which option awards will remain exercisable until the earlier of the expiration of the term of such options or 15 months from the effective date of his resignation. The performance-based option award that Mr. Segal received in February 2025 was forfeited in its entirety. In the event of a change in control within 90 days from April 11, 2025, Mr. Segal will be entitled to receive the enhanced severance benefits set forth in Section 5.7 of his June 2020 employment agreement.**

<div align='center'>39</div>

**Maria Koehler, M.D., Ph.D